Come up with a name for your new list and we'll add to it:
Celcuity raised a round of funding on December 18, 2015. Investors include
Brightstone Venture Capital.
Celcuity is developing diagnostic tests that use a patient's live tumor cells to identify the specific biological driver of their cancer. The company's CELx Signaling Function technology represents a …